一種新型非創(chuàng)傷性血管橫向全面調(diào)節(jié)器系統(tǒng)，與當(dāng)前美國(guó)心臟病學(xué)學(xué)院(ACC)和美國(guó)心臟學(xué)會(huì)(AHA)合作的外周動(dòng)脈疾病(PAD)治療指南合作，能夠測(cè)定腳踝上臂指數(shù)(ABI)、脈搏波形速率(PWV)以及增壓指數(shù)。

按照高新技術(shù)標(biāo)準(zhǔn)進(jìn)行設(shè)計(jì)的VP-系列系統(tǒng)是由Omron醫(yī)療保健公司(Bannockburn, IL, USA)開(kāi)發(fā)的，能夠?yàn)獒t(yī)生提供精確而簡(jiǎn)潔的非創(chuàng)傷性工具，對(duì)心血管疾病進(jìn)行診斷和處理。對(duì)心血管疾病的早期診斷能夠幫助醫(yī)生更早更有效地處理患者，從而改善患者的生存質(zhì)量。VP-系列產(chǎn)品使用獲得保護(hù)的波形分析和血管評(píng)估(WAVE)技術(shù)，能夠得到更加精確的結(jié)果。VP-系列產(chǎn)品包括VP-1000和功能更強(qiáng)的姐妹產(chǎn)品VP-2000。

 
Vascular Profiler Diagnoses Heart Disease
 
A new non-invasive vascular profiling system, in alignment with the current American College of Cardiology (ACC) and American Heart Association (AHA) guidelines on peripheral arterial disease (PAD) management, is capable of measuring ankle brachial index (ABI), pulse wave velocity (PWV), and augmentation index (AI).

Designed with advanced technology, the VP-Series system, developed by Omron Healthcare, Inc. (Bannockburn, IL, USA), provides physicians with accurate and easy-to-use non-invasive tools for cardiovascular disease diagnosis and management. Early detection of cardiovascular disease will enable physicians to treat patients earlier and more efficiently, thereby improving patient quality of life. The VP-Series uses patented waveform analysis and vascular evaluation (WAVE) technology to enable accurate results to achieve this goal. The VP-Series includes the VP-1000 and its more enhanced sister version, the VP- 2000.